PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption

Summary

This is an open-label, randomized study evaluating the pharmacokinetics and onset performance of Hezkue® oral sildenafil suspension administered following moderate alcohol consumption in healthy adult subjects. Participants will receive Hezkue® under controlled alcohol-exposure conditions. Pharmacokinetic sampling, onset assessments, and safety evaluations will be conducted throughout the study.

Timeline

Start

2026-03-15

Primary completion

2026-05-15

Completion

2026-05-28

Drugs

Indications

No indication recorded.